Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamila Romanowski

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 28, 2018
Demographic predictors of active tuberculosis in people migrating to British Columbia, Canada: a retrospective cohort studyLisa A Ronald, Jonathon R Campbell, Robert F Balshaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Healthcare Utilization After Respiratory Tuberculosis: A Controlled Interrupted Time Series AnalysisKamila Romanowski, Michael R Law, Mohammad Ehsanul Karim, et al.
BMJ Open|November 27, 2016
Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort studyLisa A Ronald, Jonathon R Campbell, Robert F Balshaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2025
Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-AnalysisOmri A Arbiv, Thomas Holmes, Marie JeongMin Kim, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 29, 2017
Evaluating the Timeliness of Enteric Disease Surveillance in British Columbia, Canada, 2012-13Eleni Galanis, Marsha Taylor, Kamila Romanowski, et al.
Open Forum Infectious Diseases|September 22, 2025
Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized TrialKamila Romanowski, Yen Pham Ngoc, Leila Barss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2019
Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort StudyLisa A Ronald, Jonathon R Campbell, Caren Rose, et al.
BMJ Open|November 17, 2025
Functional Outcomes, Lung health and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): study protocol for a multicentre, prospective cohort study in CanadaJonathon R Campbell, Allita Rodrigues, Eri Flores, et al.
Thorax|January 8, 2022
High-dose rifamycins in the treatment of TB: a systematic review and meta-analysisOmri A Arbiv, JeongMin M Kim, Marie Yan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2020
Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective CohortLeslie Y Chiang, Brett Baumann, Kamila Romanowski, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 28, 2018
Demographic predictors of active tuberculosis in people migrating to British Columbia, Canada: a retrospective cohort studyLisa A Ronald, Jonathon R Campbell, Robert F Balshaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Healthcare Utilization After Respiratory Tuberculosis: A Controlled Interrupted Time Series AnalysisKamila Romanowski, Michael R Law, Mohammad Ehsanul Karim, et al.
BMJ Open|November 27, 2016
Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort studyLisa A Ronald, Jonathon R Campbell, Robert F Balshaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2025
Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-AnalysisOmri A Arbiv, Thomas Holmes, Marie JeongMin Kim, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 29, 2017
Evaluating the Timeliness of Enteric Disease Surveillance in British Columbia, Canada, 2012-13Eleni Galanis, Marsha Taylor, Kamila Romanowski, et al.
Open Forum Infectious Diseases|September 22, 2025
Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized TrialKamila Romanowski, Yen Pham Ngoc, Leila Barss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2019
Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort StudyLisa A Ronald, Jonathon R Campbell, Caren Rose, et al.
BMJ Open|November 17, 2025
Functional Outcomes, Lung health and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): study protocol for a multicentre, prospective cohort study in CanadaJonathon R Campbell, Allita Rodrigues, Eri Flores, et al.
Thorax|January 8, 2022
High-dose rifamycins in the treatment of TB: a systematic review and meta-analysisOmri A Arbiv, JeongMin M Kim, Marie Yan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2020
Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective CohortLeslie Y Chiang, Brett Baumann, Kamila Romanowski, et al.
Pageof 4